We are live on ! Find out more
RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $810M
1-Year Est. Return 30.2%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+30.2%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$904M
AUM Growth
+$113M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
103
New
Increased
Reduced
Closed

Top Buys

1
+$14.7M
2
+$12.4M
3
+$9.71M
4
AXSM icon
Axsome Therapeutics
AXSM
+$9.24M
5
PRCT icon
Procept Biorobotics
PRCT
+$9.13M

Top Sells

1
+$13.9M
2
+$13.8M
3
+$11.4M
4
VRNA
Verona Pharma
VRNA
+$10.1M
5
GILD icon
Gilead Sciences
GILD
+$10M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
76
$2.78M 0.31%
53,000
77
$2.51M 0.28%
823,000
+363,000
78
$2.45M 0.27%
12,000
-14,000
79
$2.45M 0.27%
100,127
+45,000
80
$2.4M 0.27%
460,000
81
$2.38M 0.26%
1,097,827
+450,000
82
$2.36M 0.26%
+202,000
83
$2.07M 0.23%
11,750
-1,000
84
$1.94M 0.22%
165,750
85
$1.77M 0.2%
+60,000
86
$1.48M 0.16%
207,000
+162,000
87
$1.45M 0.16%
100,000
88
$1.31M 0.15%
+51,000
89
$1.2M 0.13%
+7,000
90
$1.03M 0.11%
28,278
91
$834K 0.09%
15,000
92
$262K 0.03%
+18,000
93
– –
-68,000
94
– –
-159,500
95
– –
-29,778
96
– –
-178,284
97
– –
-22,200
98
– –
-312,092
99
– –
-19,500
100
– –
-190,000
1 2 3
4
5